Skip to content

Protective Effect of Biodegradable Collagen Implant (Ologen) in Scleral Thinning After Strabismus Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02699580
Enrollment
20
Registered
2016-03-04
Start date
2015-09-30
Completion date
2016-09-10
Last updated
2017-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exotropia or Intermittent Exotropia

Keywords

Biodegradable collagen implant, scleral thinning, strabismus surgery

Brief summary

This study is to investigate protective effect of biodegradable collagen implant in scleral showing after lateral rectus recession in patients with exotropia.

Interventions

DEVICElateral rectus recession with biodegradable collagen implant

Exotropia was treated with bilateral lateral rectus recession procedure. Lateral rectus recession was done. After lateral rectus recession, no degradable collagen implant was placed in the area, where lateral rectus was original inserted. One eye was randomly selected for the comparison.

PROCEDURELateral rectus recession without biodegradable collagen implantation

Exotropia was treated with bilateral lateral rectus recession procedure. Lateral rectus recession was done in the other eye without placing biodegradable collagen implantation.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with intermittent exotropia or constant exotropia 2. Alternate prism cover test showed 20 prism diopters or more than 20 prism diopters exotropia 3. Subjects who want to do strabismus surgery

Exclusion criteria

1. Subject who had previous strabismus surgery or other ocular surgery history 2. Thyroid eye disease or other connective tissue disease 3. Significant bleeding or scleral perforation during operation 4. Subjects who need to do medial rectus resection, not lateral rectus recession 5. Subjects who had a plan to do other intra or extraocular surgery within 3 months

Design outcomes

Primary

MeasureTime frameDescription
Scleral thinning assessed with slit photographyPostoperative 3 monthsScleral thinning at the area, where lateral rectus was originally inserted, was assessed with slit photography. Scleral thinning score was calculated from the Lab color model.

Secondary

MeasureTime frameDescription
Foreign body sensation assessed by questionnairePostoperative 1 weekForeign body sensation will be assessed by questionnaire.
Collagen implant protrusion assessed by questionnairePostoperative 1 weekCollagen implant protrusion will be assessed by questionnaire.
Ocular discharge assessed by questionnairePostoperative 1 weekOcular discharge will be assessed by questionnaire.
Tearing assessed by questionnairePostoperative 1 weekTearing will be assessed by questionnaire.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026